Articles

Proven, Good Performance with the Baha Attract System

Since Cochlear introduced the Baha® Attract System one year ago, more than 2,000 people around the world have been implanted with the magnetic bone conduction solution. A clinical investigation* shows that the Baha Attract System demonstrates good performance**.

On September 7th 2014, a group of experienced surgeons gathered in Denver, Colorado, to review the global clinical data and their joint experience with the Baha Attract System. Together, the meeting participants have performed almost 100 Baha Attract surgeries in adult and pediatric patients.

The consensus of the meeting was that the Baha Attract System provides good clinical outcomes for patients with conductive hearing loss, mixed hearing loss, and single-sided sensorineural deafness, with good wearing comfort and minimal post-operative care.

Present surgeons were (from left to right):

  • Dr. Kenny Chan (Children’s Hospital Colorado, Aurora, Colorado)
  • Dr. Theodore Mason (ENT Surgeons of Western New England, Springfield, Massachusetts)
  • Dr. Wayne Berryhill (Oklahoma Otolaryngology Associates, Norman, Oklahoma)
  • Dr. Ricardo Cristobal (Texas Ear Clinic, Fort Worth, Texas)
  • Dr. Pete Weber (UMass Memorial Medical Center, Worchester, Massachusetts and Medical Advisor for Cochlear)
  • Dr. Jack Wazen (Silverstein Institute, Sarasota, Florida)
  • Dr. Aftab Patni (The Ear, Nose, Throat & Plastic Surgery Associates, Winter Park, Florida)
  • Dr. Huseyin Isildak (Penn State University Hershey Medical Center, Hershey, Pennsylvania)

New Frontiers Group

Dr. Mason, Dr. Cristobal, and Dr. Weber presented their clinical experience from Baha Attract surgeries in both adult patients and children as young as 5 years of age, with specific focus on surgical technique and surgical/medical considerations.

Dr. Cristobal and Dr. Wazen also presented case studies of 9 Baha patients, who successfully have transitioned from an abutment to a magnetic connection.

The outcomes of this meeting will be published in a positioning paper and will include guidelines for successful outcomes with the Baha Attract System.

* Clinicaltrials.gov ID NCT01822119. Clinical performance of a transcutaneous bone conduction hearing solution (Baha Attract System)

** Flynn M. C., Cochlear Baha Attract System – Summary of clinical results and benefits, Cochlear Bone Anchored Solutions AB, White paper E83112, 2014

Cochlear is pleased to announce FDA approval of the Cochlear™ Wireless Accessories for the Cochlear Nucleus® 6 Sound Processor.

With a full range of wireless accessories, Cochlear is the first and only company to deliver true wireless freedom without the need for wires or neck-worn loops. Utilizing the same 2.4 GHz wireless protocol that Bluetooth® and Wi-Fi devices depend on, Cochlear Wireless Accessories provide a streamlined connection to popular electronic devices (TVs, smartphones, and MP3 players) without the interference and signal drops that may occur with traditional wireless systems. And because ReSound wireless compatible hearing aids and the Cochlear Nucleus 6 Sound Processor share a common 2.4GHz platform, users can experience synchronized audio streaming when used together. The Cochlear…

Read More

Why Real-Ear Measures Matter for Hybrid Hearing

By: George Cire, Au.D., Regional Clinical Technical Manager, Cochlear Americas Real-ear probe tube measures provide an excellent tool for clinicians when fitting hearing aids and they can now be used to verify the acoustic fitting of EAS devices, such as the Cochlear™ Nucleus® Hybrid™ Implant System. Verification of the acoustic output of a hearing device has changed over the years. Prior to the introduction of real-ear or in-situ measurement of acoustic hearing devices in the 1980’s, clinicians working with hearing aids had to rely on functional gain measures for objective data about the benefit of the hearing instrument. Although this…

Read More

You’re Invited! Join Cochlear at CI 2014 on December 10

Please join us to hear more about the latest innovations from Cochlear at CI 2014. ACIA Symposium: Future Innovations of Implantable Hearing Solutions Date/Time: Wednesday, December 10th, 2014 | 1:00 – 4:45pm Location: Omni Nashville Presentation and Panel Topics Include:
  • Advancing Cochlear Implant Technology to Treat Hearing Loss
  • Bilateral Cochlear Implantation for Severe to Profound Hearing Loss
  • Surgical Techniques for the Preservation of Hearing
  • Programming and Performance Outcomes of Hybrid™ Hearing
  • Treating Unilateral Sensorineural Hearing Loss
Speakers and registration information, coming soon! We look forward to sharing the latest Cochlear technology with you at CI 2014.

Read More

You’re Invited! Join Cochlear at AAO 2014 on September 22

Please join us to hear more about the newest innovations from Cochlear at AAO 2014! AAO Event: Clinical Experience with New Innovations Date/Time: Monday, September 22, 2014 – 5:30pm Location: Silver Spring 1 meeting room at the Hyatt Regency Orlando RSVP here: https://www.regonline.com/AAO2014CochlearClinicalExperienceReception Topics include:
  • Hybrid™ Hearing: Performance Outcomes from Initial Activations
  • Baha® Attract System: Candidacy Considerations and Pediatric Outcomes
We look forward to sharing the latest Cochlear technology with you at AAO!

Read More